Explore All Access
Check if your research matches the topics covered in JCO Precision Oncology?
- Degree of match
- Common matching concepts
- Additional journal recommendations
JCO Precision Oncology : Impact Factor & More
eISSN: 2473-4284pISSN: 2473-4284
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
JCO Precision Oncology Key Metrics
CiteScore 
6.6
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
SJR
Q2Oncology
SNIP
0.98
Topics Covered on JCO Precision Oncology
Breast cancer
Lung cancer
Germline
Overall survival
Crizotinib
Assay
Progression-free survival
Epidermal growth factor receptor
Immunotherapy
Trametinib
BRAF V600E
Toxicity
RET Fusion
Alpha diversity
Prostate cancer
Glioblastoma
Homologous recombination
Precision medicine
Genomic profiling
Leiomyosarcoma
JCO Precision Oncology Journal Specifications
Indexed in the following public directories
Web of Science 
SJR
| Overview | |
| Publisher | LIPPINCOTT WILLIAMS & WILKINS |
| Language | English |
| Frequency | Continuous publication |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2017 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in JCO Precision Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in JCO Precision Oncology
Genomic Landscape of Malignant Phyllodes Tumors Identifies Subsets for Targeted Therapy.
- 1 Dec 2024
- JCO precision oncology
KRAS Variants Are Associated With Survival Outcomes and Genomic Alterations in Biliary Tract Cancers.
- 1 Dec 2024
- JCO precision oncology
Circulating Tumor DNA as a Prognostic Biomarker for Recurrence in Patients With Locoregional Esophagogastric Cancers With a Pathologic Complete Response.
- 1 Dec 2024
- JCO precision oncology
Discovery of Gene Fusions in Driver-Negative Cancer Samples From the National Cancer Institute-Molecular Analysis for Therapy Choice Screening Cohort.
- 1 Dec 2024
- JCO precision oncology
Evolution of Rapid Clonal Dynamics and Non-Cross-Resistance in Response to Alternating Targeted Therapy and Chemotherapy in BRAF-V600E-Mutant Colon Cancer.
- 1 Dec 2024
- JCO precision oncology
Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring BRAF Class 3 Mutations.
- 1 Dec 2024
- JCO precision oncology
Genomic Landscape of Malignant Phyllodes Tumors Identifies Subsets for Targeted Therapy.
- 1 Dec 2024
- JCO precision oncology
KRAS Variants Are Associated With Survival Outcomes and Genomic Alterations in Biliary Tract Cancers.
- 1 Dec 2024
- JCO precision oncology
Circulating Tumor DNA as a Prognostic Biomarker for Recurrence in Patients With Locoregional Esophagogastric Cancers With a Pathologic Complete Response.
- 1 Dec 2024
- JCO precision oncology
Discovery of Gene Fusions in Driver-Negative Cancer Samples From the National Cancer Institute-Molecular Analysis for Therapy Choice Screening Cohort.
- 1 Dec 2024
- JCO precision oncology
Evolution of Rapid Clonal Dynamics and Non-Cross-Resistance in Response to Alternating Targeted Therapy and Chemotherapy in BRAF-V600E-Mutant Colon Cancer.
- 1 Dec 2024
- JCO precision oncology
Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring BRAF Class 3 Mutations.
- 1 Dec 2024
- JCO precision oncology
Compare Similar Journals with JCO Precision Oncology
Select Journals to Compare with JCO Precision Oncology
Total journals - 9
You can select up to 3 Journals at a time
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Annals of Oncology
Publisher: ELSEVIER
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Cancers
Publisher: MDPI
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Clinical Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
BMC Cancer
Publisher: BMC
Oncotarget
Publisher: Impact Journals
European Journal of Cancer
Publisher: ELSEVIER SCI LTD
0 Journals Selected to compare with
JCO Precision Oncology
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on JCO Precision Oncology
How long has JCO Precision Oncology been actively publishing? 
JCO Precision Oncology has been in operation since 2017 till date.
What is the publishing frequency of JCO Precision Oncology?
JCO Precision Oncology published with a Continuous publication frequency.
How many articles did JCO Precision Oncology publish last year?
In 2023, JCO Precision Oncology publsihed 235 articles.
What is the eISSN & pISSN for JCO Precision Oncology?
For JCO Precision Oncology, eISSN is 2473-4284 and pISSN is 2473-4284.
What is Citescore for JCO Precision Oncology?
Citescore for JCO Precision Oncology is 6.6.
What is SNIP score for JCO Precision Oncology?
SNIP score for JCO Precision Oncology is 0.98.
What is the SJR for JCO Precision Oncology?
SJR for JCO Precision Oncology is Q2.
Who is the publisher of JCO Precision Oncology?
LIPPINCOTT WILLIAMS & WILKINS is the publisher of JCO Precision Oncology.
